Progression of White Matter Hyperintensities Preceded by Heterogeneous Decline of Microstructural Integrity

  • Esther M.C. van Leijsen
    From the Department of Neurology, Donders Institute for Brain, Cognition, and Behaviour, Donders Center for Medical Neuroscience (E.M.C.v.L., M.I.B., I.W.M.v.U., A.M.T., F.-E.d.L.)
  • Mayra I. Bergkamp
    From the Department of Neurology, Donders Institute for Brain, Cognition, and Behaviour, Donders Center for Medical Neuroscience (E.M.C.v.L., M.I.B., I.W.M.v.U., A.M.T., F.-E.d.L.)
  • Ingeborg W.M. van Uden
    From the Department of Neurology, Donders Institute for Brain, Cognition, and Behaviour, Donders Center for Medical Neuroscience (E.M.C.v.L., M.I.B., I.W.M.v.U., A.M.T., F.-E.d.L.)
  • Mohsen Ghafoorian
    Department of Radiology and Nuclear Medicine, Diagnostic Image Analysis Group (M.G., B.P.), Radboud University Medical Center, Nijmegen, the Netherlands
  • Helena M. van der Holst
    Department of Neurology, Jeroen Bosch Ziekenhuis, ‘s-Hertogenbosch, the Netherlands (H.M.v.d.H.)
  • David G. Norris
    Donders Institute for Brain, Cognition, and Behaviour, Centre for Cognitive Neuroimaging (D.G.N.), Radboud University, Nijmegen, the Netherlands
  • Bram Platel
    Department of Radiology and Nuclear Medicine, Diagnostic Image Analysis Group (M.G., B.P.), Radboud University Medical Center, Nijmegen, the Netherlands
  • Anil M. Tuladhar
    From the Department of Neurology, Donders Institute for Brain, Cognition, and Behaviour, Donders Center for Medical Neuroscience (E.M.C.v.L., M.I.B., I.W.M.v.U., A.M.T., F.-E.d.L.)
  • Frank-Erik de Leeuw
    From the Department of Neurology, Donders Institute for Brain, Cognition, and Behaviour, Donders Center for Medical Neuroscience (E.M.C.v.L., M.I.B., I.W.M.v.U., A.M.T., F.-E.d.L.)

抄録

<jats:sec> <jats:title>Background and Purpose—</jats:title> <jats:p>White matter hyperintensities (WMH) are frequently seen on neuroimaging of elderly and are associated with cognitive decline and the development of dementia. Yet, the temporal dynamics of conversion of normal-appearing white matter (NAWM) into WMH remains unknown. We examined whether and when progression of WMH was preceded by changes in fluid-attenuated inversion recovery and diffusion tensor imaging values, thereby taking into account differences between participants with mild versus severe baseline WMH.</jats:p> </jats:sec> <jats:sec> <jats:title>Methods—</jats:title> <jats:p>From 266 participants of the RUN DMC study (Radboud University Nijmegen Diffusion Tensor and Magnetic Resonance Imaging Cohort), we semiautomatically segmented WMH at 3 time points for 9 years. Images were registered to standard space through a subject template. We analyzed differences in baseline fluid-attenuated inversion recovery, fractional anisotropy, and mean diffusivity (MD) values and changes in MD values over time between 4 regions: (1) remaining NAWM, (2) NAWM converting into WMH in the second follow-up period, (3) NAWM converting into WMH in the first follow-up period, and (4) WMH.</jats:p> </jats:sec> <jats:sec> <jats:title>Results—</jats:title> <jats:p>NAWM converting into WMH in the first or second time interval showed higher fluid-attenuated inversion recovery and MD values than remaining NAWM. MD values in NAWM converting into WMH in the first time interval were similar to MD values in WMH. When stratified by baseline WMH severity, participants with severe WMH had higher fluid-attenuated inversion recovery and MD and lower fractional anisotropy values than participants with mild WMH, in all areas including the NAWM. MD values in WMH and in NAWM that converted into WMH continuously increased over time.</jats:p> </jats:sec> <jats:sec> <jats:title>Conclusions—</jats:title> <jats:p>Impaired microstructural integrity preceded conversion into WMH and continuously declined over time, suggesting a continuous disease process of white matter integrity loss that can be detected using diffusion tensor imaging even years before WMH become visible on conventional neuroimaging. Differences in microstructural integrity between participants with mild versus severe WMH suggest heterogeneity of both NAWM and WMH, which might explain the clinical variability observed in patients with similar small vessel disease severity.</jats:p> </jats:sec>

収録刊行物

  • Stroke

    Stroke 49 (6), 1386-1393, 2018-06

    Ovid Technologies (Wolters Kluwer Health)

被引用文献 (1)*注記

もっと見る

詳細情報 詳細情報について

問題の指摘

ページトップへ